These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18181536)

  • 1. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets.
    Gil EC; Colarte AI; Bataille B; Caraballo I
    AAPS PharmSciTech; 2007 Dec; 8(4):E115. PubMed ID: 18181536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the percolation thresholds in ternary lobenzarit disodium-dextran-HPMC hydrophilic matrices tablets: effects of initial porosity.
    Castellanos Gil E; Iraizoz Colarte A; Bataille B; Brouillet F; Caraballo I
    Eur J Pharm Sci; 2009 Nov; 38(4):312-9. PubMed ID: 19666114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Chem Pharm Bull (Tokyo); 2006 May; 54(5):598-602. PubMed ID: 16651752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the critical points of experimental HPMC-NaCMC hydrophilic matrices.
    Contreras L; Melgoza LM; Villalobos R; Caraballo I
    Int J Pharm; 2010 Feb; 386(1-2):52-60. PubMed ID: 19900524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of critical points of drugs with different solubilities in hydrophilic matrices.
    Fuertes I; Caraballo I; Miranda A; Millán M
    Int J Pharm; 2010 Jan; 383(1-2):138-46. PubMed ID: 19766706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets.
    Saurí J; Millán D; Suñé-Negre JM; Colom H; Ticó JR; Miñarro M; Pérez-Lozano P; García-Montoya E
    Int J Pharm; 2014 Dec; 477(1-2):431-41. PubMed ID: 25445523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the properties of the new biodegradable polyurethane PU (TEG-HMDI) as matrix forming excipient for controlled drug delivery.
    Campiñez MD; Aguilar-de-Leyva Á; Ferris C; de Paz MV; Galbis JA; Caraballo I
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1758-64. PubMed ID: 24087856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a new mathematical method for the estimation of the mean surface area to calculate the percolation threshold of lobenzarit disodium [correction of dissodium] salt in controlled release matrices.
    Boza A; Blanquero R; Millan M; Caraballo I
    Chem Pharm Bull (Tokyo); 2004 Jul; 52(7):797-801. PubMed ID: 15256698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis.
    Ferrero C; Massuelle D; Doelker E
    J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets.
    Aguilar-de-Leyva A; Cifuentes C; Rajabi-Siahboomi AR; Caraballo I
    Eur J Pharm Biopharm; 2012 Jan; 80(1):136-42. PubMed ID: 21946473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
    Wenzel T; Stillhart C; Kleinebudde P; Szepes A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.